Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates


Thrombocytopenia: case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.


    1. Chen S-Q, et al. Efficacy and safety evaluation of gemcitabine combined with apatinib as second line treatment in patients with recurrent/metastatic nasopharyngeal carcinoma. Chinese Journal of Cancer Prevention and Treatment 26: 1547-1550, No. 20, 28 Oct 2019. Available from: URL: http://doi.org/10.16073/j.cnki.cjcpt.2019.20.10 [Chinese; summarised from a translation]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Gemcitabine. Reactions Weekly 1790, 120 (2020). https://doi.org/10.1007/s40278-020-74739-9

    Download citation